Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
12/20/1989 | EP0346343A1 Anti-viral therapeutic composition |
12/20/1989 | CN1038103A Cycloalkyl-substituted glutaramide diuretic agents |
12/19/1989 | US4888427 Dihydropyridine-pyridinium salt redox system |
12/19/1989 | US4888416 Mixing with ionic detergent and drying |
12/19/1989 | US4888414 Insulin-binding peptides and uses thereof |
12/19/1989 | US4888398 Biodegradable polypeptide and the use thereof for the gradual release of drugs |
12/19/1989 | US4888366 Implants |
12/19/1989 | US4888339 Agent for prophylaxis and treatment of cardiac hypertrophy |
12/19/1989 | US4888280 Nucleotide sequence; dna transfer vector |
12/19/1989 | US4888172 Pharmaceutical for treating tumors and methods for making it |
12/19/1989 | EP0272309A4 Ovine inhibin. |
12/19/1989 | EP0271570A4 Use of mullerian inhibiting substance as a contraceptive agent. |
12/19/1989 | CA1263999A1 Glycopeptide antibiotics |
12/19/1989 | CA1263937A1 Polypeptide factors from colostrum |
12/14/1989 | WO1989012098A1 Hybrid proteins |
12/14/1989 | WO1989012097A1 PROCESS FOR PREPARING A FACTOR VIIa-RICH FRACTION, AND APPLICATION THEREOF AS A DRUG |
12/14/1989 | WO1989012095A1 A method of evaluating recombinant vaccines against immunodeficiency virus |
12/14/1989 | WO1989012093A1 Monoclonal antibodies against lens epithelial cells and methods for preventing proliferation of remnant lens epithelial cells after extracapsular extraction |
12/14/1989 | WO1989012069A1 Recombinant techniques for production of novel natriuretic and vasodilator peptides |
12/14/1989 | WO1989012068A2 Peptides useful for inhibiting blood vessel blockage |
12/14/1989 | WO1989012067A1 Compositions having use as treatment of psoriasis and neuropsychiatric deficits |
12/14/1989 | WO1989012066A1 Peptides with protective properties with regard to a pathogenic virus of the hiv type in sensitive cells |
12/14/1989 | WO1989012065A1 Chromatographic separation of plasma proteins |
12/14/1989 | WO1989011865A1 Monoclonal antibodies to the light chain region of human factor xii and methods of preparing and using the same |
12/14/1989 | WO1989011864A1 Method of treating myeloid leukemias |
12/14/1989 | WO1989011863A1 Bispecific antibodies |
12/14/1989 | WO1989011862A1 Actions of hormones |
12/14/1989 | WO1989011860A1 Combinations of soluble t4 proteins and anti-retroviral agents and methods for treating or preventing aids, arc and hiv infection |
12/14/1989 | WO1989011859A1 Pharmaceutical compositions and use thereof in treating inflammation |
12/13/1989 | EP0346316A2 Fusion protein and its use |
12/13/1989 | EP0346241A1 Process for preparing a factor VIIa fraction, and its use as a medicament |
12/13/1989 | EP0346114A1 Novel coleopteran-active bacillus thuringiensis isolate |
12/13/1989 | EP0346078A2 Method of inhibiting the influx of leukocytes into organs during sepsis or other trauma |
12/13/1989 | EP0346068A2 D-Cys6 vasopressin antagonists |
12/13/1989 | EP0346022A1 Peptide fragments of HIV |
12/13/1989 | EP0346014A1 Therapeutic product for the treatment of peri- or postmenopausal conditions |
12/13/1989 | EP0345990A2 Polypeptide compounds |
12/13/1989 | EP0345974A2 Cell-proliferative proteins and isolation thereof |
12/13/1989 | EP0345778A1 Peptide |
12/13/1989 | EP0345750A2 Polyfunctional protease |
12/13/1989 | EP0345660A1 Stabilized FGF composition and production thereof |
12/13/1989 | EP0345616A2 Hirudin derivatives with delayed action |
12/13/1989 | EP0345614A2 Amblyommine as an agent for use in antithrombotic therapy |
12/13/1989 | EP0345559A2 HIV-2 variants |
12/13/1989 | EP0345543A2 Therapeutic IgM concentrates |
12/13/1989 | EP0345359A1 Novel hydroxamic acid derivative |
12/13/1989 | EP0345315A1 Ps2 protein derivative |
12/13/1989 | EP0345260A1 Method of treatment of mammals using antibodies to early pregnancy factor (epf) |
12/13/1989 | EP0201509B1 Monoclonal antibody to a human carcinoma tumor associated antigen |
12/13/1989 | EP0179127B1 Leukoregulin, an antitumor lymphokine, and its therapeutic uses |
12/13/1989 | CN1037925A Monoclonal antibodies |
12/13/1989 | CN1037924A Method for improving efficacy of insect toxins |
12/12/1989 | US4886894 Novel Organic platinum complex and process for the preparation thereof |
12/12/1989 | US4886876 Factor VIII coagulant polypeptides |
12/12/1989 | US4886813 Inhibitors of angiotensin converting enzyme |
12/12/1989 | US4886780 Conjugates of apotransferrin proteins with anti-tumor agents |
12/12/1989 | US4886779 Inactivation of human immunodeficiency virus (HIV) in protein-containing solutions by phenols |
12/12/1989 | US4886758 Method of determining incompatibility-reaction-causing substances in blood products as well as a method of inactivating said incompatibility-reaction-causing substances |
12/12/1989 | US4886743 Diagnostic reagents based on unique sequences within the variable region of the T cell receptor and uses thereof |
12/12/1989 | US4886670 Anti-viral compositions |
12/12/1989 | EP0271576A4 Radioimmuno detection of human cancers using antitumor monoclonal antibody. |
12/12/1989 | CA1263842A1 Method for purifying interferon and composition of matter produced thereby |
12/06/1989 | EP0345247A2 Use of monosubstitute selenium compounds in the preparation of a pharmaceutical, pharmaceutical and preparation thereof |
12/06/1989 | EP0345246A2 Tissue adhesive |
12/06/1989 | EP0345242A2 Expression of gag proteins from retroviruses in eucaryotic cells |
12/06/1989 | EP0345021A2 Poultry mycoplasma antigens and recombinant vectors containing the gene as well as diagnostics and vaccines utilizing the same |
12/06/1989 | EP0344955A2 Novel long-chain glycolipid structure |
12/06/1989 | EP0344924A2 Fibrin-Collagen Tissue Equivalents and methods of preparation thereof |
12/06/1989 | EP0344808A1 Recombinant coccidiosis vaccines |
12/06/1989 | EP0344682A2 Oligopeptides with cyclic analogues of amino acids of proline |
12/06/1989 | EP0344643A2 Antiviral pharmaceutical composition |
12/06/1989 | EP0344572A2 Composition of angiotensin-converting-enzyme inhibitor with calcium chanell modulators and uses thereof as pharmaceuticals |
12/06/1989 | EP0344297A1 Treatment of cancer with somatostatin and analogs thereof |
12/06/1989 | EP0344239A1 Cgrp for cerebral blood supply improvement |
12/06/1989 | EP0344234A1 Antibiotic compounds |
12/06/1989 | EP0344211A1 Monoclonal antibodies in vaccine formulations |
12/06/1989 | EP0344189A1 Renin-inhibitory peptides having an epoxide or glycol moiety |
12/06/1989 | EP0344159A1 Lectin and method for the extraction thereof from scallop |
12/05/1989 | US4885293 Carboxyalkyl dipeptides |
12/05/1989 | US4885292 N-heterocyclic alcohol renin inhibitors |
12/05/1989 | US4885283 Phosphinic acid derivatives |
12/05/1989 | US4885282 Treatment of hyperhidrosis, ichthyosis and wrinkling |
12/05/1989 | US4885277 By a peptide that selectively interaccts widsth cellular receptors for factor ix |
12/05/1989 | US4885276 Cyclosporin analogs with modified "C-9 amino acids" |
12/05/1989 | US4885275 Vancomycin-HCL solutions and the lyophilization thereof |
12/05/1989 | US4885170 Antibiotic A80509 |
12/05/1989 | US4885167 Increases pumping of blood and tissue oxygenation throughout body |
12/05/1989 | US4885166 Hybrid interferons |
12/05/1989 | US4885164 Aqueous protein solutions stable to denaturation |
12/05/1989 | US4885163 Topical use of IGF-II for wound healing |
11/30/1989 | WO1989011540A1 Interleukin-1 inhibitors |
11/30/1989 | WO1989011538A1 Platelet-specific chimeric immunoglobulin |
11/30/1989 | WO1989011537A1 Antibodies |
11/30/1989 | WO1989011533A1 Cloned gene for expression of antibodies reacting with human ovarian cancer |
11/30/1989 | WO1989011531A1 Variants of plasminogen activators and processes for their production |
11/30/1989 | WO1989011492A1 Human mammary cell growth inhibitor and methods of production and use |
11/30/1989 | WO1989011491A1 Antibodies to human mammary cell growth inhibitor and methods of production and use |
11/30/1989 | WO1989011490A1 HUMAN Fcgamma RECEPTOR III |
11/30/1989 | WO1989011298A1 Formulation for antibody reagents |
11/30/1989 | WO1989011297A1 Freeze-dried formulation for antibody products |